True Vision MN LLC Buys New Position in iShares Biotechnology ETF $IBB

True Vision MN LLC bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 13,791 shares of the financial services provider’s stock, valued at approximately $2,328,000. iShares Biotechnology ETF comprises about 1.2% of True Vision MN LLC’s holdings, making the stock its 21st biggest position.

Several other institutional investors also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the second quarter worth approximately $25,000. Ashton Thomas Securities LLC bought a new stake in shares of iShares Biotechnology ETF in the third quarter valued at approximately $36,000. Parkside Financial Bank & Trust grew its stake in shares of iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 87 shares during the last quarter. Close Asset Management Ltd grew its stake in shares of iShares Biotechnology ETF by 25.5% in the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after acquiring an additional 70 shares during the last quarter. Finally, Founders Financial Alliance LLC increased its position in iShares Biotechnology ETF by 605.7% during the third quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock worth $54,000 after acquiring an additional 321 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Trading Down 2.9%

NASDAQ:IBB opened at $160.41 on Friday. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64. The company has a fifty day moving average price of $171.17 and a 200 day moving average price of $164.06.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.